Connection
Wells Messersmith to Esophageal Neoplasms
This is a "connection" page, showing publications Wells Messersmith has written about Esophageal Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.110 |
|
|
|
-
Almhanna K, Miron ML, Wright D, Gracian AC, Hubner RA, Van Laethem JL, L?pez CM, Alsina M, Mu?oz FL, Bendell J, Firdaus I, Messersmith W, Ye Z, Fasanmade AA, Danaee H, Kalebic T. Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C. Invest New Drugs. 2017 04; 35(2):235-241.
Score: 0.110